<DOC>
	<DOCNO>NCT02090387</DOCNO>
	<brief_summary>The study evaluate effect oral nutritional supplement ( ONS ) attenuate lean body mass ( LBM ) loss occur bed rest .</brief_summary>
	<brief_title>Evaluation Oral Nutritional Supplement Lean Body Mass Healthy Older Subjects .</brief_title>
	<detailed_description />
	<criteria>1 . Age ≥ 60 ≤ 79 year 2 . Body Mass Index ( BMI ) &gt; 20 ≤ 35 kg/m2 . 3 . Short Physical Performance Battery ( SPPB ) score &gt; 9 ( fully functional mobility limitation ) . 4 . Triacylglyceride ( TAG ) level ≤ 250 mg/dl , LDL cholesterol ≤ 155 mg/dl , total cholesterol level ≤ 250 mg/dl . 5 . Compliance various activity level require study . 6 . Ankle brachial index within normal range , 1 1.4 . 7 . Physical activity score within 2008 Guidelines Americans . 8 . Normalgood handgrip strength . 1 . Type I Type II Diabetes Mellitus . 2 . Fasting blood glucose level &gt; 115 mg/dl . 3 . Major surgery , less 6 week prior enrollment study , subject plan elective surgery require 2 day hospitalization . 4 . History pressure ulcer . 5 . Stated history Deep Vein Thrombosis ( DVT ) , recent elevate Ddimer test , positive ultrasound DVT , pulmonary embolism , carotid atherosclerosis , transient ischemic attack ( TIA ) , state hypercoaguable condition , clot bleed disorder , currently prescribe blood thinner . 6 . Varicose vein would result significant discomfort wear TED hose and/or SCD . 7 . Stated autoimmune disease active malignant disease . 8 . Estimated glomerular filtration rate &lt; 50ml/min/1.73m2 . 9 . Current significantly impair liver function hepatic enzyme test ≥2.5 time normal limit . 10 . Significant cardiovascular event ≤ 6 month prior screen visit ; state history congestive heart failure . 11 . Untreated hypo hyperthyroidism , endocrinopathies associate excessive androgen secretion . 12 . Refractory anemia hemoglobin value &lt; 11.0 g/dl . 13 . Chronic , contagious , infectious disease , active tuberculosis , hepatitis B C , HIV . 14 . Current infection ( require prescription antimicrobial antiviral medication , hospitalization ) , receive corticosteroid treatment ( exception inhale topical steroid ) last 3 month . 15 . Currently prescribed pain/antiinflammatory medication and/or regularly consume counter pain/antiinflammatory medication chronic , persistent , pain , include limited arthritic condition , fibromyalgia , continuous localize pain . 16 . History allergy ingredient study product . 17 . Deleted 18 . Obstruction gastrointestinal tract preclude ingestion study product , inflammatory bowel disease , short bowel syndrome severe form gastrointestinal disease . 19 . Stated uncontrolled severe diarrhea , nausea vomiting . 20 . Amputee . 21 . Actively pursue weight loss gain . 22 . Can refrain take medications/dietary supplement ( form ) /substances could modulate metabolism body weight . 23 . Can refrain take long chain n3 polyunsaturated fatty acid ( PUFA ) ( eicosapentaenoic acid ( EPA ) ± docosahexaenoic acid ( DHA ) ± αlinolenic acid ( ALA ) ) , vitamin D , level significantly high establish Acceptable Macronutrient Distribution Range ( AMDR ) , recommend American Heart Association ( 500 mg/d total EPA+DHA ) , study . 24 . Can refrain smoking discontinue use nicotine ( form include patch ) tobacco study . 25 . One metal implant . 26 . Currently diagnosis history severe dementia delirium , eat disorder , history significant neurological psychiatric disorder , alcoholism , substance abuse condition may interfere study product consumption compliance . 27 . Can abstain alcohol use study .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>